Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service

Go back to Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
StemCells, Inc. (NASDAQ: TEM) Delayed: 46.96 --0 (-0%)
Previous Close $46.96    52 Week High $0.45 
Open $46.96    52 Week Low $0.37 
Day High $46.96    P/E N/A 
Day Low $46.96    EPS $-0.31 
Volume 100,882